Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China-Reference-Cited by-同舟云学术

Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China

Published:2019-01-01 Issue:1 Volume:24 Page:631-636
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Ye Naifang¹²,Liu Zhenzhen¹,Xu Guanqun¹,Wang Xuefeng¹,Wu Fang³,Xu Xiaoqian⁴,Wu Wenman¹⁵

Affiliation:

1. Department of Clinical Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

2. Department of Clinical Laboratory Medicine, The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, People’s Republic of China

3. Department of Geriatrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China

4. Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China

5. Faculty of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2019.1663028

Reference28 articles.

1. Acquired Haemophilia - a study of ten cases

2. Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia

3. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

4. The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients

5. Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line immunosuppressive therapies for acquired hemophilia A: A 25-year cohort experience and network meta-analysis;Thrombosis Research;2024-09

2. Prednisone;Reactions Weekly;2019-11